Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD), in rats and mice
- 1 December 1990
- journal article
- Published by Elsevier in Toxicology
- Vol. 65 (1-2) , 179-197
- https://doi.org/10.1016/0300-483x(90)90088-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.BMJ, 1988
- Uptake of a fluorinated bisphosphonate by cultured bonesBone, 1988
- Distribution of [14C]clodronate (dichloromethylene bisphosphonate) disodium in miceToxicology and Applied Pharmacology, 1987
- Experimental Basis for the Use of Bisphosphonates in Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1987
- Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.Annals of the Rheumatic Diseases, 1986
- RENAL FAILURE ASSOCIATED WITH INTRAVENOUS DIPHOSPHONATESThe Lancet, 1983
- Urinary enzymes, nephrotoxicity and renal diseaseToxicology, 1982
- Enzymes of renal origin in urine as indicators of nephrotoxicity*1Toxicology and Applied Pharmacology, 1977
- Renal secretion of diphosphonates in ratsKidney International, 1975
- Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkeyToxicology and Applied Pharmacology, 1972